hrsv
lead
caus
lower
respiratori
tract
infect
lrti
bronchiol
pneumonia
infant
children
year
age
caus
morbid
mortal
popul
prematur
infant
children
heart
lung
diseas
immunocompromis
individu
etc
hrsv
also
signific
caus
morbid
mortal
adult
impact
approach
influenza
viru
reinfect
hrsv
occur
throughout
life
annual
epidem
occur
winter
month
temper
hrsv
famili
paramyxovirida
ordo
mononegaviral
envelop
viru
neg
sens
rna
genom
kb
length
viral
genom
consist
gene
code
protein
follow
order
n
p
sh
g
f
l
two
group
hrsva
hrsvb
describ
base
reaction
monoclon
antibodi
g
f
g
protein
integr
membran
protein
consist
amino
acid
facilit
viru
attach
suscept
cell
host
ectodomain
g
protein
consist
two
hypervari
region
split
highli
conserv
acid
length
aa
domain
addit
g
glycoprotein
chang
antigen
region
locat
end
protein
commonli
use
molecular
analys
highest
degre
divers
subgroup
within
consid
antigen
genet
analysi
genotyp
hrsva
genotyp
hrsvb
thb
genet
divers
hrsv
genotyp
occurr
new
genotyp
may
chang
pathogen
facilit
evas
exist
host
immun
recent
novel
hrsva
genotyp
duplic
within
report
canada
dissemin
surveil
hrsv
infect
outbreak
molecular
analysi
viru
need
investig
whether
novel
genotyp
spread
worldwid
caus
larger
outbreak
data
regard
molecular
epidemiolog
hrsv
gener
turkey
thu
far
therefor
aim
studi
investig
circul
pattern
viru
conduct
phylogenet
molecular
analysi
differ
genotyp
hrsva
b
strain
nasopharyng
aspir
npa
collect
infant
hospit
children
acut
lower
respiratori
tract
infect
alrti
paediatr
allergi
immunolog
clinic
depart
children
health
paediatr
haematolog
oncolog
train
research
hospit
ankara
januari
decemb
randomli
collect
sampl
paediatr
clinic
hospit
adult
also
includ
studi
diagnosi
alrti
base
presenc
symptomssign
acut
respiratori
ill
cough
fever
nasal
discharg
chest
pain
sputum
product
increas
respiratori
rate
age
retract
dyspnea
ronchi
crepit
auscult
radiolog
evid
alrti
time
admiss
clinic
featur
patient
laboratori
find
evalu
npa
sampl
place
ml
viral
transport
medium
minimum
essenti
medium
eagl
meme
sigma
taufkirchen
germani
vortex
centrifug
supernat
frozen
store
test
viral
genom
rna
grna
extract
npa
supernat
use
qiagen
viru
mini
kit
advanc
extract
robot
qiagen
hilden
germani
accord
manufactur
instruct
intern
control
sampl
test
presenc
human
respiratori
syncyti
viru
hrsv
use
fast
track
diagnosticsrespiratori
pathogen
commerci
kit
luxembourg
influenza
viru
influenza
viru
b
rhinoviru
respiratori
syncyti
viru
ab
parainfluenza
viru
coronaviru
parechoviru
enteroviru
adenoviru
human
bocaviru
human
metapneumoviru
ic
use
abi
pcr
platform
appli
biosystem
foster
citi
ca
perform
use
manufactur
protocol
fast
track
diagnosticsrespiratori
pathogen
sampl
ct
valu
subject
rt
pcr
partial
amplifi
g
protein
code
region
grna
subsequ
phylogenet
analysi
genet
analysi
hrsv
carboxi
terminu
g
protein
code
region
amplifi
use
qiagen
one
step
kit
qiagen
accord
manufactur
instruct
expect
amplif
product
size
b
ba
bueno
air
ba
strain
contain
sequenc
hrsv
duplic
attach
g
protein
gene
hr
virus
bp
bp
bp
respect
second
run
pcr
first
run
pcr
product
ad
reaction
mix
contain
taq
dna
polymeras
qiagen
group
b
virus
forward
primer
respect
revers
primer
use
describ
sullend
et
length
amplifi
dna
product
b
ba
virus
bp
bp
bp
respect
nucleotid
sequenc
amplifi
pcr
product
purifi
use
qiagen
pcr
purif
kit
qiagen
qiaquick
gel
extract
kit
qiagen
agaros
gel
cycl
sequenc
perform
use
bigdy
termin
cycl
sequenc
kit
appli
biosystem
direct
sequenc
data
gener
abi
genet
analyz
appli
biosystem
sequenc
manual
edit
multipl
sequenc
align
gener
use
clustal
x
ident
sequenc
identifi
damb
softwar
version
align
sequenc
studi
refer
sequenc
perform
clustalw
programm
hrsva
b
phylogenet
tree
construct
neighbour
join
method
use
substitut
model
nucleotid
complet
delet
gap
miss
data
treatment
replic
bootstrap
probabl
within
mega
partial
nucleotid
sequenc
g
gene
belong
six
epidem
season
deposit
genbank
access
number
hrsv
refer
sequenc
use
studi
shown
supplement
b
spss
softwar
spss
inc
chicago
il
use
statist
analysi
signific
differ
rate
among
variou
group
test
student
fisher
exact
test
statist
signific
consid
valu
p
total
sampl
process
pcr
hrsv
posit
hrsv
posit
accord
year
given
figur
approxim
total
sampl
hrsv
posit
major
popul
afflict
hrsv
infect
infant
children
month
age
occurr
hrsv
variou
age
group
follow
year
age
year
age
year
age
year
age
older
year
age
figur
although
hrsv
activ
start
approxim
week
viru
activ
start
week
season
usual
epidemiolog
peak
reach
around
week
winter
figur
hrsva
hrsvb
six
epidem
season
hrsva
domin
epidem
season
except
season
hrsvb
domin
genotyp
tabl
clinic
data
avail
patient
monitor
due
alrti
especi
bronchiol
patient
male
median
age
month
month
iqr
also
consid
distribut
hrsv
posit
accord
gender
seen
male
commonli
infect
femal
figur
thirteen
patient
mix
viral
infect
six
patient
rhinoviru
one
patient
adenoviru
two
patient
human
bocaviru
two
patient
influenza
b
viru
one
patient
parainfluenza
viru
one
patient
parainfluenza
viru
patient
posit
hrsva
posit
hrsvb
patient
patient
hrsvb
common
symptom
observ
subgroup
includ
cough
hrsva
hrsvb
respect
wheez
rhinorrhoea
fever
patient
group
similar
length
hospit
laboratori
find
treatment
tabl
partial
sequenc
analysi
region
g
gene
hrsva
hrsvb
align
repres
sequenc
identifi
refer
genotyp
phylogenet
tree
shown
figur
accord
novel
genotyp
criteria
propos
venter
et
group
phylogenet
cluster
bootstrap
valu
p
distanc
valu
smaller
genotyp
belong
hrsva
genotyp
genotyp
belong
hrsvb
genotyp
identifi
countri
bootstrap
valu
cluster
valu
cluster
cui
et
describ
novel
genotyp
china
name
genotyp
defin
amino
acid
auksornkitti
et
describ
novel
genotyp
thailand
call
thb
amino
acid
substitut
ren
et
report
genotyp
china
amino
acid
substitut
thb
strain
cluster
branch
bootstrap
valu
figur
neither
ren
et
auksornkitti
et
includ
genotyp
studi
obviou
three
genotyp
ident
genotyp
partial
sequenc
region
g
gene
hrsva
hrsvb
success
obtain
mean
nucleotid
divers
within
hrsva
hrsvb
four
put
site
identifi
hrsva
relat
prototyp
strain
detect
one
na
strain
major
strain
detect
strain
remain
conserv
strain
strain
site
region
turkey
strain
thr
ser
residu
genotyp
thr
ser
thr
ser
could
site
site
posit
identifi
conserv
spot
hrsvb
strain
turkey
strain
nine
success
nucleotid
insert
site
conserv
relat
hrsvba
prototyp
strain
site
region
identifi
region
hrsvb
turkey
strain
approxim
thr
ser
residu
predict
length
amino
acid
respect
strain
novel
subgenotyp
detect
substitut
includ
furthermor
substitut
observ
strain
report
uniqu
two
substitut
conserv
turkey
strain
supplement
length
g
protein
amino
acid
turkey
strain
four
turkey
strain
amino
acid
posit
insert
nine
success
nucleotid
acaaaaaaa
code
thr
ly
k
ly
k
relat
prototyp
strain
detect
amino
acid
substitut
report
conserv
turkey
strain
etc
novel
genotyp
substitut
novel
genotyp
substitut
relat
hrsvba
prototyp
strain
supplement
distribut
genotyp
belong
hrsv
season
given
tabl
observ
domin
genotyp
two
season
domin
season
domin
season
detect
four
success
epidem
season
detect
epidem
season
hrsv
common
viral
pathogen
caus
lower
respiratori
tract
infect
among
infant
young
incid
bronchiol
pneumonia
highest
infant
increas
age
incid
studi
bronchiol
common
subtyp
accord
clinic
analysi
pediatr
patient
higher
suscept
hrsv
infect
occur
age
year
infect
popul
infant
children
month
hrsv
preval
decreas
children
year
old
preval
hrsv
decreas
children
older
year
lower
immun
respons
earli
year
develop
soonest
children
second
third
signific
differ
clinic
symptom
similar
length
hospit
laboratori
find
treatment
observ
hrsva
hrsvb
group
coinfect
studi
although
clinic
differ
hrsv
genotyp
baek
et
note
hrsvb
infect
rel
greater
impact
diseas
sever
coinfect
obviou
impact
diseas
studi
male
commonli
infect
femal
mention
rsv
caus
epidem
begin
winter
spring
temper
climat
activ
may
differ
hrsv
infect
appear
end
novemb
peak
januari
turkey
usual
epidemiolog
peak
reach
around
week
winter
consid
genotyp
analys
genotyp
six
studi
epidem
season
hrsv
group
domin
report
worldwid
genotyp
domin
genotyp
variabl
mani
studi
hrsva
virus
frequent
turkey
hrsva
domin
two
success
epidem
season
hrsva
replac
hrsvb
season
domin
next
season
hrsvb
replac
hrsva
epidem
season
replac
subgroup
affect
variou
factor
adapt
host
antigen
variant
social
although
consid
emerg
subgenotyp
studi
detect
sampl
domin
genotyp
hrsva
turkey
turkey
strain
lost
site
except
one
strain
amino
acid
substitut
two
site
detect
substitut
potenti
site
identifi
epidem
season
turkey
becam
domin
subgenotyp
requir
monitor
whether
amino
acid
substitut
would
affect
spread
viru
hrsvb
identifi
turkey
hrsv
b
genotyp
detect
countri
sinc
domin
japan
korea
china
four
site
detect
season
domin
preval
societi
would
provid
social
immun
caus
chang
viral
structur
similarli
detect
year
hrsva
domin
length
g
protein
hrsvb
variabl
due
chang
amino
acid
substitut
insert
stop
codon
polymorph
g
protein
hrsvb
hrsva
four
strain
nine
nucleotid
insert
nucleotid
present
insert
place
determin
cui
et
strain
associ
chang
g
protein
length
antigen
variat
report
mani
studi
antibodi
respons
induc
hrsva
may
provid
cross
protect
hrsvb
hrsvb
undergo
extens
antigen
variat
evad
herd
recent
report
novel
variant
bac
within
hrsv
subgroup
seem
circul
also
remain
domest
propos
reich
result
indic
hrsv
strain
may
develop
independ
monitor
whether
novel
genotyp
temporari
establish
stabl
linag
popul
addit
import
mutat
viru
develop
herd
immun
divers
region
g
protein
play
signific
role
hrsv
pathogenesi
facilit
evas
immun
result
indic
ectodomain
g
protein
hrsv
glycosyl
sugar
contribut
major
part
thb
genotyp
classifi
genotyp
strongli
recommend
use
genotyp
due
prioriti
rule
similar
issu
detect
strain
cluster
branch
bootstrap
valu
figur
addit
genotyp
cluster
genotyp
present
studi
provid
addit
inform
molecular
epidemiolog
hrsv
turkey
present
data
compar
analysi
hrsv
stain
circul
local
commun
region
worldwid
find
may
improv
understand
hrsv
evolut
potenti
develop
hrsv
vaccin
